Metabolomics Workbench : NIH Data Repository

Analysis	Metabolite Name	Measured Value	Units	CASE_CONTROL	Chemotherapy	Drug	Race	TIMEPOINT	Tamoxyfen	Taxane
Reversed phase NEGATIVE ION MODE	CITRAMALATE (CAS# 2306-22-1); (M-H)-	1182	Peak area	Case	N	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	CITRAMALATE (CAS# 2306-22-1); (M-H)-	1339	Peak area	Case	N	Letrozole	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	CITRAMALATE (CAS# 2306-22-1); (M-H)-	2101	Peak area	Case	N	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	CITRAMALATE (CAS# 2306-22-1); (M-H)-	2293	Peak area	Control	Y	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	CITRAMALATE (CAS# 2306-22-1); (M-H)-	2944	Peak area	Case	N	Letrozole	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	CITRAMALATE (CAS# 2306-22-1); (M-H)-	3423	Peak area	Control	N	Letrozole	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	CITRAMALATE (CAS# 2306-22-1); (M-H)-	3975	Peak area	Case	Y	Letrozole	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	CITRAMALATE (CAS# 2306-22-1); (M-H)-	4142	Peak area	Control	Y	Exemestane	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	CITRAMALATE (CAS# 2306-22-1); (M-H)-	4186	Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	CITRAMALATE (CAS# 2306-22-1); (M-H)-	4226	Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	CITRAMALATE (CAS# 2306-22-1); (M-H)-	5470	Peak area	Case	N	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	CITRAMALATE (CAS# 2306-22-1); (M-H)-	5603	Peak area	Case	N	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	CITRAMALATE (CAS# 2306-22-1); (M-H)-	7348	Peak area	Control	N	Letrozole	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	CITRAMALATE (CAS# 2306-22-1); (M-H)-	8789	Peak area	Control	N	Letrozole	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	CITRAMALATE (CAS# 2306-22-1); (M-H)-	9814	Peak area	Control	N	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	CITRAMALATE (CAS# 2306-22-1); (M-H)-	12026	Peak area	Control	Y	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	CITRAMALATE (CAS# 2306-22-1); (M-H)-	13003	Peak area	Case	N	Letrozole	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	CITRAMALATE (CAS# 2306-22-1); (M-H)-	13665	Peak area	Control	Y	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	CITRAMALATE (CAS# 2306-22-1); (M-H)-	17422	Peak area	Case	N	Letrozole	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	CITRAMALATE (CAS# 2306-22-1); (M-H)-	20228	Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	CITRAMALATE (CAS# 2306-22-1); (M-H)-	21412	Peak area	Control	Y	Exemestane	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	CITRAMALATE (CAS# 2306-22-1); (M-H)-	22121	Peak area	Case	N	Exemestane	Black	Baseline	N	N
Reversed phase NEGATIVE ION MODE	CITRAMALATE (CAS# 2306-22-1); (M-H)-	22549	Peak area	Case	N	Exemestane	Black	3 Month	N	N
Reversed phase NEGATIVE ION MODE	CITRAMALATE (CAS# 2306-22-1); (M-H)-	27005	Peak area	Case	Y	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	CITRAMALATE (CAS# 2306-22-1); (M-H)-	31505	Peak area	Case	N	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	CITRAMALATE (CAS# 2306-22-1); (M-H)-		Peak area	Case	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	CITRAMALATE (CAS# 2306-22-1); (M-H)-		Peak area	Case	N	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	CITRAMALATE (CAS# 2306-22-1); (M-H)-		Peak area	Case	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	CITRAMALATE (CAS# 2306-22-1); (M-H)-		Peak area	Case	N	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	CITRAMALATE (CAS# 2306-22-1); (M-H)-		Peak area	Case	N	Letrozole	Black	3 Month	N	N
Reversed phase NEGATIVE ION MODE	CITRAMALATE (CAS# 2306-22-1); (M-H)-		Peak area	Case	N	Letrozole	Black	Baseline	N	N
Reversed phase NEGATIVE ION MODE	CITRAMALATE (CAS# 2306-22-1); (M-H)-		Peak area	Case	N	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	CITRAMALATE (CAS# 2306-22-1); (M-H)-		Peak area	Case	N	Letrozole	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	CITRAMALATE (CAS# 2306-22-1); (M-H)-		Peak area	Case	N	Letrozole	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	CITRAMALATE (CAS# 2306-22-1); (M-H)-		Peak area	Case	Y	Exemestane	Black	3 Month	N	Y
Reversed phase NEGATIVE ION MODE	CITRAMALATE (CAS# 2306-22-1); (M-H)-		Peak area	Case	Y	Exemestane	Black	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	CITRAMALATE (CAS# 2306-22-1); (M-H)-		Peak area	Case	Y	Exemestane	White	3 Month	N	Y
Reversed phase NEGATIVE ION MODE	CITRAMALATE (CAS# 2306-22-1); (M-H)-		Peak area	Case	Y	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	CITRAMALATE (CAS# 2306-22-1); (M-H)-		Peak area	Case	Y	Exemestane	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	CITRAMALATE (CAS# 2306-22-1); (M-H)-		Peak area	Case	Y	Exemestane	White	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	CITRAMALATE (CAS# 2306-22-1); (M-H)-		Peak area	Case	Y	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	CITRAMALATE (CAS# 2306-22-1); (M-H)-		Peak area	Case	Y	Exemestane	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	CITRAMALATE (CAS# 2306-22-1); (M-H)-		Peak area	Case	Y	Letrozole	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	CITRAMALATE (CAS# 2306-22-1); (M-H)-		Peak area	Case	Y	Letrozole	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	CITRAMALATE (CAS# 2306-22-1); (M-H)-		Peak area	Control	N	Exemestane	Black	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	CITRAMALATE (CAS# 2306-22-1); (M-H)-		Peak area	Control	N	Exemestane	Black	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	CITRAMALATE (CAS# 2306-22-1); (M-H)-		Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	CITRAMALATE (CAS# 2306-22-1); (M-H)-		Peak area	Control	N	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	CITRAMALATE (CAS# 2306-22-1); (M-H)-		Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	CITRAMALATE (CAS# 2306-22-1); (M-H)-		Peak area	Control	N	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	CITRAMALATE (CAS# 2306-22-1); (M-H)-		Peak area	Control	N	Letrozole	Black	3 Month	N	N
Reversed phase NEGATIVE ION MODE	CITRAMALATE (CAS# 2306-22-1); (M-H)-		Peak area	Control	N	Letrozole	Black	Baseline	N	N
Reversed phase NEGATIVE ION MODE	CITRAMALATE (CAS# 2306-22-1); (M-H)-		Peak area	Control	N	Letrozole	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	CITRAMALATE (CAS# 2306-22-1); (M-H)-		Peak area	Control	N	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	CITRAMALATE (CAS# 2306-22-1); (M-H)-		Peak area	Control	N	Letrozole	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	CITRAMALATE (CAS# 2306-22-1); (M-H)-		Peak area	Control	N	Letrozole	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	CITRAMALATE (CAS# 2306-22-1); (M-H)-		Peak area	Control	Y	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	CITRAMALATE (CAS# 2306-22-1); (M-H)-		Peak area	Control	Y	Exemestane	White	3 Month	N	Y
Reversed phase NEGATIVE ION MODE	CITRAMALATE (CAS# 2306-22-1); (M-H)-		Peak area	Control	Y	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	CITRAMALATE (CAS# 2306-22-1); (M-H)-		Peak area	Control	Y	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	CITRAMALATE (CAS# 2306-22-1); (M-H)-		Peak area	Control	Y	Exemestane	White	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	CITRAMALATE (CAS# 2306-22-1); (M-H)-		Peak area	Control	Y	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	CITRAMALATE (CAS# 2306-22-1); (M-H)-		Peak area	Control	Y	Letrozole	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	CITRAMALATE (CAS# 2306-22-1); (M-H)-		Peak area	Control	Y	Letrozole	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	CITRAMALATE (CAS# 2306-22-1); (M-H)-		Peak area	Control	Y	Letrozole	White	Baseline	Y	Y
Reversed phase POSITIVE ION MODE	CITRAMALATE (CAS# 2306-22-1); (M+H)+	1645	Peak area	Control	Y	Exemestane	White	3 Month	Y	Y
Reversed phase POSITIVE ION MODE	CITRAMALATE (CAS# 2306-22-1); (M+H)+		Peak area	Case	N	Exemestane	Black	3 Month	N	N
Reversed phase POSITIVE ION MODE	CITRAMALATE (CAS# 2306-22-1); (M+H)+		Peak area	Case	N	Exemestane	Black	Baseline	N	N
Reversed phase POSITIVE ION MODE	CITRAMALATE (CAS# 2306-22-1); (M+H)+		Peak area	Case	N	Exemestane	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	CITRAMALATE (CAS# 2306-22-1); (M+H)+		Peak area	Case	N	Exemestane	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	CITRAMALATE (CAS# 2306-22-1); (M+H)+		Peak area	Case	N	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	CITRAMALATE (CAS# 2306-22-1); (M+H)+		Peak area	Case	N	Exemestane	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	CITRAMALATE (CAS# 2306-22-1); (M+H)+		Peak area	Case	N	Letrozole	Black	3 Month	N	N
Reversed phase POSITIVE ION MODE	CITRAMALATE (CAS# 2306-22-1); (M+H)+		Peak area	Case	N	Letrozole	Black	Baseline	N	N
Reversed phase POSITIVE ION MODE	CITRAMALATE (CAS# 2306-22-1); (M+H)+		Peak area	Case	N	Letrozole	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	CITRAMALATE (CAS# 2306-22-1); (M+H)+		Peak area	Case	N	Letrozole	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	CITRAMALATE (CAS# 2306-22-1); (M+H)+		Peak area	Case	N	Letrozole	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	CITRAMALATE (CAS# 2306-22-1); (M+H)+		Peak area	Case	N	Letrozole	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	CITRAMALATE (CAS# 2306-22-1); (M+H)+		Peak area	Case	Y	Exemestane	Black	3 Month	N	Y
Reversed phase POSITIVE ION MODE	CITRAMALATE (CAS# 2306-22-1); (M+H)+		Peak area	Case	Y	Exemestane	Black	Baseline	N	Y
Reversed phase POSITIVE ION MODE	CITRAMALATE (CAS# 2306-22-1); (M+H)+		Peak area	Case	Y	Exemestane	White	3 Month	N	Y
Reversed phase POSITIVE ION MODE	CITRAMALATE (CAS# 2306-22-1); (M+H)+		Peak area	Case	Y	Exemestane	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	CITRAMALATE (CAS# 2306-22-1); (M+H)+		Peak area	Case	Y	Exemestane	White	3 Month	Y	Y
Reversed phase POSITIVE ION MODE	CITRAMALATE (CAS# 2306-22-1); (M+H)+		Peak area	Case	Y	Exemestane	White	Baseline	N	Y
Reversed phase POSITIVE ION MODE	CITRAMALATE (CAS# 2306-22-1); (M+H)+		Peak area	Case	Y	Exemestane	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	CITRAMALATE (CAS# 2306-22-1); (M+H)+		Peak area	Case	Y	Exemestane	White	Baseline	Y	Y
Reversed phase POSITIVE ION MODE	CITRAMALATE (CAS# 2306-22-1); (M+H)+		Peak area	Case	Y	Letrozole	White	3 Month	Y	Y
Reversed phase POSITIVE ION MODE	CITRAMALATE (CAS# 2306-22-1); (M+H)+		Peak area	Case	Y	Letrozole	White	Baseline	Y	Y
Reversed phase POSITIVE ION MODE	CITRAMALATE (CAS# 2306-22-1); (M+H)+		Peak area	Control	N	Exemestane	Black	3 Month	Y	N
Reversed phase POSITIVE ION MODE	CITRAMALATE (CAS# 2306-22-1); (M+H)+		Peak area	Control	N	Exemestane	Black	Baseline	Y	N
Reversed phase POSITIVE ION MODE	CITRAMALATE (CAS# 2306-22-1); (M+H)+		Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	CITRAMALATE (CAS# 2306-22-1); (M+H)+		Peak area	Control	N	Exemestane	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	CITRAMALATE (CAS# 2306-22-1); (M+H)+		Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	CITRAMALATE (CAS# 2306-22-1); (M+H)+		Peak area	Control	N	Exemestane	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	CITRAMALATE (CAS# 2306-22-1); (M+H)+		Peak area	Control	N	Letrozole	Black	3 Month	N	N
Reversed phase POSITIVE ION MODE	CITRAMALATE (CAS# 2306-22-1); (M+H)+		Peak area	Control	N	Letrozole	Black	Baseline	N	N
Reversed phase POSITIVE ION MODE	CITRAMALATE (CAS# 2306-22-1); (M+H)+		Peak area	Control	N	Letrozole	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	CITRAMALATE (CAS# 2306-22-1); (M+H)+		Peak area	Control	N	Letrozole	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	CITRAMALATE (CAS# 2306-22-1); (M+H)+		Peak area	Control	N	Letrozole	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	CITRAMALATE (CAS# 2306-22-1); (M+H)+		Peak area	Control	N	Letrozole	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	CITRAMALATE (CAS# 2306-22-1); (M+H)+		Peak area	Control	Y	Exemestane	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	CITRAMALATE (CAS# 2306-22-1); (M+H)+		Peak area	Control	Y	Exemestane	White	3 Month	N	Y
Reversed phase POSITIVE ION MODE	CITRAMALATE (CAS# 2306-22-1); (M+H)+		Peak area	Control	Y	Exemestane	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	CITRAMALATE (CAS# 2306-22-1); (M+H)+		Peak area	Control	Y	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	CITRAMALATE (CAS# 2306-22-1); (M+H)+		Peak area	Control	Y	Exemestane	White	Baseline	N	Y
Reversed phase POSITIVE ION MODE	CITRAMALATE (CAS# 2306-22-1); (M+H)+		Peak area	Control	Y	Exemestane	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	CITRAMALATE (CAS# 2306-22-1); (M+H)+		Peak area	Control	Y	Exemestane	White	Baseline	Y	Y
Reversed phase POSITIVE ION MODE	CITRAMALATE (CAS# 2306-22-1); (M+H)+		Peak area	Control	Y	Letrozole	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	CITRAMALATE (CAS# 2306-22-1); (M+H)+		Peak area	Control	Y	Letrozole	White	3 Month	Y	Y
Reversed phase POSITIVE ION MODE	CITRAMALATE (CAS# 2306-22-1); (M+H)+		Peak area	Control	Y	Letrozole	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	CITRAMALATE (CAS# 2306-22-1); (M+H)+		Peak area	Control	Y	Letrozole	White	Baseline	Y	Y